Cell and Gene Therapy, Cell Therapy
January 14, 2026
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing, Partnerships, Tech Transfer
January 07, 2026
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing, Partnerships, Tech Transfer
December 16, 2025
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-only) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing
December 08, 2025
FDA approves Omisirge® as First Approved Cell Therapy to Treat Severe Aplastic Anemia
Cell and Gene Therapy, Cell Therapy
September 16, 2025
dPCR vs. ddPCR: Why Precision Matters in Cell and Gene Therapy
Cell and Gene Therapy, Cell Therapy, Leadership
May 29, 2025
Future Directions for Process Development
Cell and Gene Therapy, Cell Therapy, Leadership
May 05, 2025
Centralized vs. Point-of-Care Manufacturing
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing, Tech Transfer
March 11, 2025